Search

Lihong E Wang

from Fremont, CA
Age ~55
Get Report
Also known as:
Lihong L Wang, Linda Wang, Hong Wang Li
Phone and address:
31 Palacio Ct, Fremont, CA 94539
(510) 375-2456
Related to:
Ping Tan Li, 71Charles Q Wu, 60Fang H Tsui, 63Alexis Li, 48Yu C LiJinzhong Wang, 50
Connected to:
Aaron Wang, 36Aijie Wang, 54Ailin Y Wang, 67Aiying Wang, 63Alex F Wang, 51Alexandra Wang, 50Alfred C Wang, 47Ally H Wang, 50Amerfil M Wang, 80Andreas Wang, 28

Lihong Wang Phones & Addresses

  • 31 Palacio Ct, Fremont, CA 94539 (510) 375-2456
  • Mission Viejo, CA
  • Union City, CA
  • San Mateo, CA
  • San Ramon, CA
  • Millbrae, CA
  • Alameda, CA

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lihong Wang
President
AGILE LHW TECHNOLOGY INC
1175 Chess Dr SUITE 203, San Mateo, CA 94404

Publications

Isbn (Books And Publications)

Biomedical Optics: Principles and Imaging

View page
Author

Lihong V. Wang

ISBN #

0471743046

1999 International Conference on Biomedical Optics

View page
Author

Lihong V. Wang

ISBN #

0819434558

Photons Plus Ultrasound: Imaging And Sensing

View page
Author

Lihong V. Wang

ISBN #

0819452289

Photons plus Ultrasound: Imaging and Sensing 2006

View page
Author

Lihong V. Wang

ISBN #

0819461288

Us Patents

Humanized Monoclonal Antibodies To Hepatocyte Growth Factor

View page
US Patent:
7632926, Dec 15, 2009
Filed:
Mar 29, 2007
Appl. No.:
11/731774
Inventors:
Kyung Jin Kim - Cupertino CA, US
Hangil Park - San Francisco CA, US
Lihong Wang - Palo Alto CA, US
Maximiliano Vasquez - Palo Alto CA, US
Assignee:
Galaxy Biotech, LLC - Cupertino CA
International Classification:
C07K 16/00
C07K 16/24
C07K 16/26
A61K 39/00
A61K 39/395
US Classification:
53038823, 5303871, 5303881, 53038815, 53038824, 4241301, 4241411, 4241421, 4241451
Abstract:
The present invention is directed toward a humanized neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Monoclonal Antibodies To Basic Fibroblast Growth Factor

View page
US Patent:
8101725, Jan 24, 2012
Filed:
May 28, 2009
Appl. No.:
12/474198
Inventors:
Kyung Jin Kim - Cupertino CA, US
Lihong Wang - Palo Alto CA, US
Hangil Park - San Francisco CA, US
Maximiliano Vasquez - Palo Alto CA, US
Assignee:
Galaxy Biotech, LLC - Cupertino CA
International Classification:
C07K 16/22
A61K 39/395
US Classification:
5303881, 53038824, 4241411, 4241421, 4241451
Abstract:
The present invention is directed toward a neutralizing monoclonal antibody to basic fibroblast growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Humanized Monoclonal Antibodies To Hepatocyte Growth Factor

View page
US Patent:
8628778, Jan 14, 2014
Filed:
Sep 29, 2009
Appl. No.:
12/569463
Inventors:
Kyung Jin Kim - Cupertino CA, US
Hangil Park - San Francisco CA, US
Lihong Wang - Palo Alto CA, US
Maximiliano Vasquez - Palo Alto CA, US
Assignee:
Galaxy Biotech, LLC - Sunnyvale CA
International Classification:
A61K 39/395
US Classification:
4241451, 4241411, 4241361, 4241331, 4241301
Abstract:
The present invention is directed toward a humanized neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Monoclonal Antibodies To Hepatocyte Growth Factor

View page
US Patent:
20040208876, Oct 21, 2004
Filed:
Apr 15, 2004
Appl. No.:
10/825060
Inventors:
Kyung Kim - Cupertino CA, US
Yi-Chi Su - San Francisco CA, US
Lihong Wang - Palo Alto CA, US
International Classification:
A61K039/395
C12N005/06
C07K016/22
US Classification:
424/145100, 530/388250, 435/326000
Abstract:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Monoclonal Antibodies To Hepatocyte Growth Factor

View page
US Patent:
20050019327, Jan 27, 2005
Filed:
Aug 13, 2004
Appl. No.:
10/917915
Inventors:
Kyung Kim - Cupertino CA, US
Yi-Chi Su - San Francisco CA, US
Lihong Wang - Palo Alto CA, US
International Classification:
A61K039/395
C07K016/22
US Classification:
424145100, 530388250
Abstract:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Monoclonal Antibodies To Basic Fibroblast Growth Factor

View page
US Patent:
20130209482, Aug 15, 2013
Filed:
Dec 15, 2011
Appl. No.:
13/327624
Inventors:
Kyung Jin Kim - Cupertino CA, US
Lihong Wang - Palo Alto CA, US
Hangil Park - San Francisco CA, US
Maximiliano Vasquez - Palo Alto CA, US
Assignee:
Galaxy Biotech, LLC - Cupertino CA
International Classification:
C07K 16/28
US Classification:
4241451, 53038824, 5303873, 53038815
Abstract:
The present invention is directed toward a neutralizing monoclonal antibody to basic fibroblast growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Highly Potent Antibodies Binding To Death Receptor 4 And Death Receptor 5

View page
US Patent:
20210238297, Aug 5, 2021
Filed:
Feb 2, 2021
Appl. No.:
17/165818
Inventors:
- CUPERTINO CA, US
Hangil Park - San Francisco CA, US
Lihong Wang - Hayward CA, US
Yi Ding - Milpitas CA, US
April Zhang - San Jose CA, US
Maximiliano Vasquez - Palo Alto CA, US
Assignee:
GALAXY BIOTECH, LLC - CUPERTINO CA
International Classification:
C07K 16/28
A61P 35/00
Abstract:
The present invention is directed toward monoclonal antibodies that bind to death receptor 4 and/or death receptor 5, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Highly Potent Monoclonal Antibodies To Angiogenic Factors

View page
US Patent:
20190352386, Nov 21, 2019
Filed:
Sep 13, 2016
Appl. No.:
15/759471
Inventors:
- Sunnyvale CA, US
Hangil Park - San Francisco CA, US
Yi Ding - Milpitas CA, US
April Zhang - San Jose CA, US
Lihong Wang - Hayward CA, US
Maximiliano Vasquez - Palo Alto CA, US
International Classification:
C07K 16/22
A61P 35/00
Abstract:
The present invention is directed toward neutralizing monoclonal antibodies to Vascular Endothelial Growth Factor (VEGF) and angiopoietin 2 (Ang-2), pharmaceutical compositions comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Control profile
Lihong E Wang from Fremont, CA, age ~55 Get Report